MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine ...

We recently released our second quarter 2025 earnings, along with important corporate updates regarding the ongoing launch and rollout of VLN ® products. VLN ® cigarettes are the first and only ...

22nd Century Group, Inc. (XXII) is one of the most interesting stocks in biotechnology right now. The company, which bills itself as a biotechnology company and is based in New York, has developed a ...

Detailed price information for 22nd Century Group Inc (XXII-Q) from The Globe and Mail including charting and trades.

MCLEAN, Va., March 25, 2026 /PRNewswire/ -- 22nd Century Technologies, Inc. (TSCTI), a leading provider of digital transformation and enterprise technology solutions for public and private sectors, ...

Welcome to 22nd Century Group's Third Quarter 2025 Conference Call and Webcast. [Operator Instructions] It is now my pleasure to turn the floor over to Matt Kreps, Investor Relations for 22nd Century ...

Headquartered in Buffalo, New York, 22nd Century Group is a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research.

MOCKSVILLE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a ...

22nd Century has hired TD Cowen as advisers. It cautioned that there is no deadline for completing the review, and “there is no assurance that the strategic alternatives process will result in the ...

22nd Century Group, Inc. (NASDAQ:XXII) Q1 2025 Earnings Call Transcript May 13, 2025 22nd Century Group, Inc. misses on earnings expectations. Reported EPS is $-1.89 EPS, expectations were $-1.1.